In the UK, 63% of OTC users agree that painkillers designed for specific types of pain are more effective than general pain remedies, suggesting opportunities to create more targeted pain relief solutions.
The OTC Analgesics and Cough, Cold, and Flu Remedies Market in the UK has shown steady growth, with over 5% increase in value sales in 2024.
Historically, the market has benefited from consistent demand, driven by the prevalence of ailments and seasonal spikes, such as the “quad-demic” in 2024, which boosted the sales in the cold remedies market and flu remedies market. Over the past few years, innovation in the market has been slow, with repackaging and relaunches dominating, but there is increasing consumer interest in targeted and personalised solutions. Looking forward, the OTC Analgesics and Cough, Cold and Flu Remedies Market is forecasted to grow more than 6% in the foreseeable future, with opportunities in integrating technology, like medication tracking apps and wearable devices. However, challenges such as inflation and supply chain disruptions may temper growth, although the essential nature of over the counter pharmaceuticals market ensures their resilience. The market will continue to be driven by consumer demand for both affordability and efficacy in remedies.
Consumer trends in the UK OTC Analgesics and Cough, Cold and Flu Remedies Market show a growing preference for targeted and specific pain relief solutions, with many consumers opting for remedies tailored to particular ailments like headaches, menstrual pain, and sinus discomfort. There is a noticeable shift towards oral remedies, such as paracetamol, with increasing interest in fast-acting and efficacy-driven products. Additionally, a significant portion of consumers (44%) are open to using smartphone apps to track their medication, reflecting a trend towards integrating technology for more personalised health management. While traditional remedies remain popular, there is a rising demand for simpler, more affordable products, with own-label brands capitalising on this trend. Furthermore, marketing is becoming more personalised, targeting specific demographics such as older adults and parents, with social media and influencer campaigns driving engagement. This shift is particularly evident in both the Cough Remedies Market and the Cold Remedies Market, where consumers are becoming more discerning about the efficacy and convenience of the products they choose.
Purchasing the UK OTC Analgesics and Cough, Cold, and Flu Remedies Market Report 2025 reveals that younger consumers prefer targeted, tech-driven remedies, while older consumers stick to traditional, budget-friendly options. The report also highlights growing demand for ingredient transparency and sustainability, driving the market toward more personalised and ethical products.
The UK OTC Analgesics and Cough, Cold, and Flu Remedies Market Report 2025 provides comprehensive insights into consumer preferences, Over the Counter Remedies Market trends, and future growth opportunities. The report covers key areas such as product innovation, demand for targeted pain relief solutions, the rise of tech-driven health management tools, and the growing emphasis on ingredient transparency and sustainability. It surveys various consumer demographics, including age groups, purchasing behaviors, and their preferences for both traditional and modern remedies. This OTC Analgesics and Cough, Cold and Flu Remedies Market Report is invaluable for industry stakeholders, including manufacturers, retailers, marketers, and investors, helping them make informed decisions and align their strategies with evolving OTC remedies market demands.
| Report Attributes | Details |
|---|---|
| Published Date | May 2025 |
| Data Range | 2019-2029 |
| Measurement Metrics | Revenue in £ |
| Country Focus | United Kingdom (UK) |
| Consumer Data | 1,954 internet users aged 18+, March 2025 |
| Number of Pages | 98 |
| Market Segmentation | Oral Pain Remedies, Topical Pain Remedies, Cold/Flu Remedies, Cough Liquids, Medicated Confectionery, Decongestant Nasal Sprays, Decongestant Tablets/Capsules, and Other OTC Remedies. |
| Leading Companies | Nurofen, Solpadeine, Voltarol, Panadol, Anadin, Galpharm, Essential Waitrose, Vicks, Weleda, Jakemans, Boots, and Otrivine. |
This report was written by Ziyu Tian. Ziyu joined the UK BPCH team in February 2025, having previously worked as an English-Chinese translator in the localisation team for over three years. In her current role, she analyses and writes reports focusing on the OTC and personal care categories as well as the annual ‘A year of innovation’ reports.
To excite the OTC market, there are opportunities to broaden innovation with targeted and combination treatments, as well as tech integration, to personalise pain and ailment management.
Ziyu Tian
OTC & Personal Care Research Analyst
We utilize Mintel Reports, Trends and Comperemedia to mine for insights across the numerous business verticals that Epsilon serves, such as CPG, automotive, telecom, healthcare/pharma, retail and financial services.
By integrating Mintel insight into new business opportunities, we have been able to gain the competitive edge necessary to advance partnerships with global brands and key business players.
For our organization, it’s about depth and breadth. Having one without the other doesn’t enable success in our business.
We use Mintel to inform our thinking and reinforce strategy. If you’re presenting new ideas, it’s essential they are underpinned by robust data and evidence, and clearly rooted in fact.
Mintel gives us all that. It’s a great brand and one that is trusted by clients.
When I’m investigating specific sectors I tend to use Mintel reports for their forecasting, which I’ve always found to be very accurate.
They also offer really broad and deep coverage in their reports. They are very, very detailed. For example, we were able to gain insight across a wide range of business areas from just one report, proving that Mintel is excellent value for money.
So overall, it’s the level of detail and the quality of forecasting that really stand out for me.
At Jackman, we believe that powerful strategies are based on human insight. Mintel’s leading-edge reports and insights into consumer attitudes and behaviors are an important input as we develop and execute strategy.
We have such a great working relationship with Mintel on lots of different levels. As an insight partner, they have helped us to develop our business planning in specific categories as well as supporting our creative process but they’ve also been super helpful with facilitating our events in their inspirational offices near St Paul’s.
They’re an innovative company, with a client-focused team that always delivers.
